Finance
Company's third quarter revenue positively affected by HIV, HCV contracts
Published in Vaccine Weekly, November 20th, 2002
"Third quarter revenue increased 8.6%, driven primarily by strong activity in two service contracts related to HIV vaccine development and hepatitis C," said Kevin W. Quinlan, Boston Biomedica, Inc. "This was partially offset by disappointing product revenue, caused primarily by postponed and cancelled orders as the current economic downturn in the IVD industry hurt our customers' test kit sales and new test development. The result was an unfavorable mix shift that adversely impacted gross margin and operating performance.
"Nonetheless we remain encouraged as we...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2002-11-20)
More Articles from Vaccine Weekly
- Cancer Vaccine
Stromal cell-derived factor 1 effective against leukemia and melanoma in murine models - Infectious Disease Vaccine
Rotavirus vaccine could protect children from infection and related diarrhea - Childhood Immunization
More resources needed to vaccinate 95% of all children - Influenza Vaccine
Review article covers details involved in developing effective influenza vaccines - Meningitis Vaccine
Meningococcal C conjugate vaccine safe and effective - AIDS Resistance
Study shows why some immune systems control HIV - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
